Use of tivozanib to treat subjects with refractory cancer | Patent Number 11504365
US 11504365 B2Filled DateApr 14, 2022
Priority DateNov 5, 2018
Publication DateJul 28, 2022
Expiration DateNov 4, 2038
Inventor/ApplicantsMichael N. Needle
Michael P. Bailey
Michael P. Bailey
ExaminesKOSTURKO, GEORGE W
Art Unit1628
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.